• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Innovent Biologics

Roche
Biotech

Roche returns to Innovent with new $1B biobucks ADC drug deal

Roche has signed a new biobucks-heavy pact that aims to add another new antibody-drug conjugate asset to its pipeline.
Ben Adams Jan 2, 2025 3:19am
blocks stack target climb build arrow meet

Awaiting regulator verdict, Innovent posts latest psoriasis win

Oct 29, 2024 9:50am
Colon cancer

ESMO: Innovent links cytokine to colorectal cancer responses

Sep 18, 2024 9:53am
Sketch of lungs

Innovent links IL-2 fusion protein to responses in small study

Jun 14, 2024 10:00am
iris eye eyeball eye art

Innovent's Tepezza rival closer to China nod after phase 3 win

Feb 20, 2024 8:38am
target reach ladder climb meet win beat competition

Next-gen Lilly obesity drug secures first phase 3 win for Innovent

Jan 9, 2024 5:29am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings